1.
R Galanello, A Piga, GL Forni, Y Bertrand, ML Foschini, E Bordone, G Leoni, A Lavagetto, A Zappu, F Longo, H Maseruka, N Hewson, R Sechaud, R Belleli, D Alberti. Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major. haematol [Internet]. 2006Jan.1 [cited 2022Dec.6];91(10):1343-51. Available from: https://haematologica.org/article/view/4176